CM
SWAV

Castleark Management’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Castleark Management’s Portfolio SWAV Stock Details SWAV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-13,680
Closed -$3.9M – 325
2023
Q2 		$3.9M Buy
+13,680
New +$3.8M 0.18% 131
2023
Q1 		– Sell
-11,359
Closed -$2.34M – 331
2022
Q4 		$2.34M Sell
11,359
-23,695
-68% -$5.99M 0.12% 154
2022
Q3 		$9.75M Sell
35,054
-13,770
-28% -$3.5M 0.54% 37
2022
Q2 		$9.33M Sell
48,824
-525
-1% -$92.7K 0.5% 35
2022
Q1 		$10.2M Buy
49,349
+4,990
+11% +$823K 0.44% 39
2021
Q4 		$7.91M Sell
44,359
-17,950
-29% -$3.54M 0.29% 85
2021
Q3 		$12.8M Sell
62,309
-23,230
-27% -$4.56M 0.49% 51
2021
Q2 		$16.2M Sell
85,539
-3,570
-4% -$584K 0.55% 40
2021
Q1 		$11.6M Buy
89,109
+17,585
+25% +$2.11M 0.42% 66
2020
Q4 		$7.42M Sell
71,524
-25,920
-27% -$2.24M 0.28% 98
2020
Q3 		$7.39M Buy
97,444
+39,114
+67% +$2.22M 0.29% 103
2020
Q2 		$2.76M Buy
+58,330
New +$2.4M 0.12% 161

Other funds holding SWAV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return

Castleark Management's SWAV Position: Q3 2023 in Review

Castleark Management sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q3 2023, closing a stake of 13,680 shares — an estimated $3.9M sold.

Castleark Management first reported a position in SWAV in Q2 2020 and held it in 12 quarters. The position peaked at $16.2M in Q2 2021. 412 funds tracked by Wall St. Rank hold SWAV as of Q3 2023.

  • Castleark Management reported no remaining Shockwave Medical, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Castleark Management sold 13,680 Shockwave Medical, Inc. Common Stock shares in Q3 2023, an estimated $3.9M.
  • Castleark Management first reported a position in Shockwave Medical, Inc. Common Stock in Q2 2020 and held it in 12 quarters.
  • Castleark Management's Shockwave Medical, Inc. Common Stock position peaked at $16.2M in Q2 2021.
  • 412 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q3 2023.

Based on Castleark Management's 13F filing for Q3 2023, filed 15 Nov 2023.